Long, full eyelashes have been treated as a beauty standard across cultures for centuries, and the search for ways to grow them is nothing new \u2014 mascara, false lashes, and lash extensions have all filled that gap for decades. But the more interesting development came from an unexpected place: glaucoma medicine. Patients using prostaglandin eye drops to treat elevated eye pressure kept reporting the same surprising side effect \u2014 longer, thicker, darker eyelashes.<\/p>\n\n\n\n
Latanoprost was one of the very first drugs where this was observed. So, can you actually use latanoprost specifically for eyelash growth? The short answer is: it does have a real effect, but it isn’t the prostaglandin drug that ended up approved \u2014 or best suited \u2014 for that purpose. Here’s the full picture.<\/p>\n\n\n\n
Since latanoprost’s introduction in 1996 as a glaucoma treatment, eyelash growth has been consistently reported as a side effect of regular use. Patients using latanoprost eye drops have observed lashes becoming noticeably longer, thicker, and more numerous over weeks to months of treatment. This isn’t anecdotal \u2014 it’s been documented in clinical studies that tracked lash characteristics in patients using the medication for IOP control.<\/p>\n\n\n\n
So the effect is real. The complication is what happened next in the broader prostaglandin category.<\/p>\n\n\n\n
Latanoprost and bimatoprost are closely related prostaglandin-class drugs, and both were observed to produce eyelash growth as an incidental effect of glaucoma treatment. But when pharmaceutical companies pursued FDA approval specifically for cosmetic eyelash enhancement, it was bimatoprost<\/strong>, not latanoprost, that went through that process.<\/p>\n\n\n\n In 2008, bimatoprost (marketed as Latisse, with generic and lower-cost versions like Careprost) became the first and remains the only FDA-approved treatment for eyelash hypotrichosis \u2014 inadequate or sparse lashes \u2014 for cosmetic use. Clinical comparisons have generally found bimatoprost to be the more potent eyelash enhancer of the two drugs, which is part of why it became the commercial product, while latanoprost’s lash-growth effect remained a secondary, unapproved side effect rather than a marketed use.<\/p>\n\n\n\n In practical terms, this means:<\/strong><\/p>\n\n\n\n The exact mechanism isn’t fully mapped out, but research suggests the medication acts on the hair growth cycle itself. Eyelash follicles cycle through three phases: anagen (active growth), catagen (transition), and telogen (resting\/shedding). Prostaglandin analogues appear to:<\/p>\n\n\n\n Importantly, the medication doesn’t increase the actual number<\/em> of follicles a person has. The fuller appearance comes from more existing follicles being in an active growth phase at the same time, rather than from new lashes being created.<\/p>\n\n\n\n Some people seeking eyelash-growth treatments<\/strong><\/a> aren’t simply chasing a cosmetic upgrade \u2014 they’re dealing with a real loss of lashes, a condition called madarosis. This can be caused by trauma, hypothyroidism, certain medications, radiation, or, less commonly, infection. As long as the hair follicles themselves remain intact, normal lash growth typically resumes once the underlying cause is identified and treated. Prostaglandin-based treatments can be a useful tool in this recovery process, though addressing the root cause remains the priority.<\/p>\n\n\n\n If your goal is purely cosmetic \u2014 fuller, longer lashes with no glaucoma diagnosis involved \u2014 bimatoprost (Careprost) is the better-suited and better-studied option, specifically formulated and approved for this use. Using latanoprost off-label for this purpose isn’t well supported by the same body of research, and any prostaglandin eye drop should only be used under medical guidance, given the potential side effects described below.<\/p>\n\n\n\n\n
How Prostaglandin Eye Drops Grow Eyelashes<\/h2>\n\n\n\n
\n
What About Eyelash Loss (Madarosis)?<\/h2>\n\n\n\n
Should You Use Latanoprost for Lashes, or Switch to Bimatoprost?<\/h2>\n\n\n\n